Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination.
Saved in:
| Title: | Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination. |
|---|---|
| Authors: | Revon-Riviere G; Department of Pediatric Oncology & Hematology.; Marseille Early Phases Cancer Trials Center CLIP², Aix Marseille University APHM, Marseille., Soler C; Hematology Department, Hôpital l'Archet CHU de Nice, Nice, France., Andrianarivony T; Department of Pediatric Oncology & Hematology., Fily S; Department of Pediatric Oncology & Hematology., André N; Department of Pediatric Oncology & Hematology.; Marseille Early Phases Cancer Trials Center CLIP², Aix Marseille University APHM, Marseille. |
| Source: | Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2021 Oct 01; Vol. 43 (7), pp. e1045-e1046. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505928 Publication Model: Print Cited Medium: Internet ISSN: 1536-3678 (Electronic) Linking ISSN: 10774114 NLM ISO Abbreviation: J Pediatr Hematol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
